Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.
PHASE4CompletedINTERVENTIONAL
Enrollment
300
Participants
Timeline
Start Date
December 31, 2002
Study Completion Date
June 30, 2005
Conditions
Parkinson's Disease
Interventions
DRUG
Comtess®
Trial Locations (1)
22607 Hamburg
Orion Pharma GmbH, Hamburg
All Listed Sponsors
lead
Orion Corporation, Orion Pharma
INDUSTRY
NCT00247247 - Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off. | Biotech Hunter | Biotech Hunter